Financial Statements
Financials
Q2 – (JULY TO SEPTEMBER)
Financial Result for 30th September 2020
- Eris Investor Presentation 30th September 2020
- Transcript of the Analyst and Investor Conference Call Q2FY21
- Newspaper advertisement for Extract of Result for September, 2020
- Intimation for Earning Calls Q2 FY21
- Notice of Board Meeting November 03, 2020
- Disclosure of Related Party Transactions on a Consolidated Basis – September 2020
Q2 – (JULY TO SEPTEMBER)
- Financial Result for 30th September 2019
- Eris Investor Presentation 30th September 2019
- Transcript of the Analyst and Investor Conference Call – Q2FY20
- Newspaper advertisement for Extract of Result for September, 2019
- Notice of Board Meeting November 7 2019
- Intimation for Earnings Call Q2FY20
- Disclosure of Related Party Transactions on a Consolidated Basis – September 2019
Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Q4 – (JANUARY TO MARCH)
- Financial Result for 31st March 2019
- Eris Investor Presentation 31st March 2019
- Transcript of the Analyst and Investor Conference Call Q4FY19
- Newspaper advertisement for Extract of Result for March, 2019
- Notice of Board Meeting May 21, 2019
- Disclosure of Related Party Transactions on a Consolidated Basis
- Earnings call Intimation for the Q4 FY2018-2019
Q2 – (JULY TO SEPTEMBER)
Q4 – (JANUARY TO MARCH)
Copyright © 2021 Eris Lifesciences Limited. All Rights Reserved.